Aloe-emodin-8-O-beta-D-glucopyranoside

CAS No. 33037-46-6

Aloe-emodin-8-O-beta-D-glucopyranoside( —— )

Catalog No. M21678 CAS No. 33037-46-6

Aloe-emodin-8-O-beta-D-glucopyranoside shows moderate bioactivity against human Protein Tyrosine Phosphatase 1B (hPTP1B) in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 300 Get Quote
10MG 511 Get Quote
25MG 807 Get Quote
50MG 1062 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Aloe-emodin-8-O-beta-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Aloe-emodin-8-O-beta-D-glucopyranoside shows moderate bioactivity against human Protein Tyrosine Phosphatase 1B (hPTP1B) in vitro.
  • Description
    Aloe-emodin-8-O-beta-D-glucopyranoside shows moderate bioactivity against human Protein Tyrosine Phosphatase 1B (hPTP1B) in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    PTP1B
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    33037-46-6
  • Formula Weight
    432.38
  • Molecular Formula
    C21H20O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (115.64 mM)
  • SMILES
    OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(cccc1C(c2cc(CO)cc(O)c22)=O)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.PTP1B inhibitors from Saussrurea lappa.J Asian Nat Prod Res. 2006 Apr-May;8(3):281-6.
molnova catalog
related products
  • MB05032

    MB05032 is a potent fructose-,-bisphosphatase inhibitor that inhibits gluconeogenesis and reduces d-lactate-triggered ETosis.

  • BCI hydrochloride

    BCI hydrochloride ((E)-BCI hydrochloride) is a selective dual-specificity phosphatase 6 (DUSP6) inhibitor that inhibits RANKL-mediated osteoclastogenesis and attenuates oophorectomy-induced bone loss.

  • Calcineurin Autoinhi...

    Selective inhibitor of Ca2+-calmodulin-dependent protein phosphatase (calcineurin) (IC50 ~ 10 μM). Does not inhibit PP1, PP2A or CaM kinase II (IC50 > 100 mM).